Welcome to LookChem.com Sign In|Join Free

CAS

  • or

115314-14-2

Post Buying Request

115314-14-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

115314-14-2 Usage

Uses

Different sources of media describe the Uses of 115314-14-2 differently. You can refer to the following data:
1. (S)-(+)-Glycidyl Nosylate is a compound useful in organic synthesis.
2. (S)-(+)-Glycidyl Nosylate (cas# 115314-14-2) is a compound useful in organic synthesis.

Chemical Properties

white to light yellow crystal powde

Check Digit Verification of cas no

The CAS Registry Mumber 115314-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,5,3,1 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 115314-14:
(8*1)+(7*1)+(6*5)+(5*3)+(4*1)+(3*4)+(2*1)+(1*4)=82
82 % 10 = 2
So 115314-14-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO6S/c11-10(12)7-2-1-3-9(4-7)17(13,14)16-6-8-5-15-8/h1-4,8H,5-6H2

115314-14-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (G0287)  (S)-Glycidyl 3-Nitrobenzenesulfonate  >98.0%(GC)

  • 115314-14-2

  • 5g

  • 790.00CNY

  • Detail
  • TCI America

  • (G0287)  (S)-Glycidyl 3-Nitrobenzenesulfonate  >98.0%(GC)

  • 115314-14-2

  • 25g

  • 2,690.00CNY

  • Detail
  • Alfa Aesar

  • (H64289)  Glycidyl (S)-(+)-3-nitrobenzenesulfonate, 98%   

  • 115314-14-2

  • 1g

  • 245.0CNY

  • Detail
  • Alfa Aesar

  • (H64289)  Glycidyl (S)-(+)-3-nitrobenzenesulfonate, 98%   

  • 115314-14-2

  • 5g

  • 882.0CNY

  • Detail
  • Alfa Aesar

  • (H64289)  Glycidyl (S)-(+)-3-nitrobenzenesulfonate, 98%   

  • 115314-14-2

  • 25g

  • 3528.0CNY

  • Detail

115314-14-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-Glycidyl 3-Nitrobenzenesulfonate

1.2 Other means of identification

Product number -
Other names (S)-Glycidyl 3-nitrobenzenesulfonate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:115314-14-2 SDS

115314-14-2Relevant articles and documents

New propranolol analogues: Binding and chiral discrimination by cellobiohydrolase Cel7A

Fagerstroem, Alexandra,Nilsson, Mikael,Berg, Ulf,Isaksson, Roland

, p. 3067 - 3076 (2006)

Novel propranolol analogues have been designed and synthesised and their enantioselective binding to the cellulose degrading enzyme, Cel7A, has been evaluated. Affinity and enantioselectivity have been determined by capillary electrophoresis experiments. Ligands with significantly improved affinity and selectivity have been obtained and an analysis of the results has led to insights concerning the relation between the changes in ligand structure and selectivity as well as affinity to the protein. The Royal Society of Chemistry 2006.

AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF

-

Paragraph 01608, (2019/05/10)

The present disclosure relates to amine-substituted heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., cancer) by administering an amine-substituted heterocyclic heterocyclic compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.

Synthesis and biological evaluation of new simple indolic non peptidic HIV Protease inhibitors: The effect of different substitution patterns Dedicated to CINMPIS on the occasion of its 20th anniversary.

Bonini,Chiummiento,Di Blasio,Funicello,Lupattelli,Tramutola,Berti,Ostric,Miertus,Frecer,Kong

, p. 4792 - 4802 (2014/10/15)

New structurally simple indolic non peptidic HIV Protease inhibitors were synthesized from (S)-glycidol by regioselective methods. Following the concept of targeting the protein backbone, different substitution patterns were introduced onto the common stereodefined isopropanolamine core modifying the type of functional group on the indole, the position of the functional group on the indole and the type of the nitrogen containing group (sulfonamides or perhydroisoquinoline), alternatively. The systematic study on in vitro inhibition activity of such compounds confirmed the general beneficial effect of the 5-indolyl substituents in presence of arylsulfonamide moieties, which furnished activities in the micromolar range. Preliminary docking analysis allowed to identify several key features of the binding mode of such compounds to the protease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 115314-14-2